Therapeutic potential for KCC2-targeted neurological diseases

• Главные авторы: Kazuo Tomita (Автор), Yoshikazu Kuwahara (Автор), Kento Igarashi (Автор), Junichi Kitanaka (Автор), Nobue Kitanaka (Автор), Yuko Takashi (Автор), Koh-ichi Tanaka (Автор), Mehryar Habibi Roudkenar (Автор), Amaneh Mohammadi Roushandeh (Автор), Akihiro Kurimasa (Автор), Yoshihiro Nishitani (Автор), Tomoaki Sato (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2023-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Patients with neurological diseases, such as schizophrenia, tend to show low K+-Cl- co-transporter 2 (KCC2) levels in the brain. The cause of these diseases has been associated with stress and neuroinflammation. However, since the pathogenesis of these diseases is not yet fully investigated, drug th...